Catalyst Fellowships launched to support talented child health researchers
14 Dec 2017, 4:32 p.m.
The Catalyst Fellowships are an exciting new initiative supported by the National Institute for Health Research (NIHR) Great Ormond Street Hospital (GOSH) Biomedical Research Centre aiming to build the capacity of child health researchers and enabling them to become the research leaders of the future.The fellowship, which provides up to 18 months of salary support, will help talented individuals take the next step towards establishing themselves as independent researchers. Applications are invited from clinical and non-clinical trainees.
The Catalyst Fellowships have been spearheaded by the recently-established GOSH BRC Junior Faculty, a group that aims to support the career development of junior researchers.
This new fellowship is a reflection of the importance that GOSH and ICH place on nurturing the next generation of paediatric researchers. This funding will support junior researchers in making the transition to senior leaders and allow them to develop their careers within the world-class research environment of GOSH and ICH.
The deadline for applications is Thursday 1st March 2018.
Application form and eligibility criteria (.docx) (0 bytes)
Ancient gene mutation found as the cause of rare hereditary condition for GOSH patient.
UK scientists have found that a 7,000-year-old genetic mutation is responsible for a rare form of hereditary motor neuropathy (HMN).
Scientists build whole functioning thymus from human cells
Researchers from two leading national organisations have rebuilt a human thymus using human stem cells and a bioengineered scaffold thanks to support from the NIHR GOSH Biomedical Research Centre (BRC). Their work, which has been published in Nature Commu
Leukaemia trial shows promise and complexity of genome-edited cell therapies
A ‘one size fits all’ immune therapy developed at the UCL Great Ormond Street Institute of Child Health (ICH) could help to clear cancerous cells in children and adults who have exhausted all other treatment options for B-cell acute lymphoblastic leukaemi
GOSH researchers join experts in warning of the detrimental impact of a no deal Brexit on rare diseases
Experts have warned that a ‘no deal’ Brexit will result in the exclusion of the UK from the 24 European Reference Networks (ERNs) that were established to improve the care of patients bearing the lifelong burden of a rare disease, which require highly spe